论文部分内容阅读
Infliximab(商品名Remicade)是人/鼠嵌合的抗肿瘤坏死因子(tumournecrosisfactor,TNF)-α单克隆抗体,在国外该药已用于治疗早期和慢性类风湿关节炎(rheumatoidarthritis,RA)、强直性脊柱炎(ankylosingspondylitis,AS)、银屑病关节炎和克罗恩病(Crohn’sdisease,CD)。多数研究显?
Infliximab (Remicade) is a human / mouse chimeric anti-tumor necrosis factor (TNF) -α monoclonal antibody that has been used abroad for the treatment of early and chronic rheumatoid arthritis (RA) Ankylosponsive polycythemia (AS), psoriatic arthritis and Crohn’s disease (CD). Most studies show?